Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» New anti-PD1 drugs overpriced, ICER says
New anti-PD1 drugs overpriced, ICER says
New anti-PD1 drugs overpriced, ICER says
Submitted by
admin
on October 6, 2016 - 9:37am
Source:
BioPharma Dive
News Tags:
drug pricing
ICER
anti-PD-L1
Opdivo
Keytruda
Bristol-Myers Squibb
Merck
Headline:
New anti-PD1 drugs overpriced, ICER says
